Skip to content

Analgesic effect and muscle activity of Electrical Cortical Stimulation assited by Peripheral Electrical Stimulation in healthy volunteers

Effects of Electrical Cortical Stimulation assisted by Peripheral Electrical Stimulation (priming) on ??activation of descending pain inhibitory pathway and electrical muscle activity in healthy volunteers

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
REBEC
Registry ID
RBR-5vwfqyx
Enrollment
Unknown
Registered
2024-03-18
Start date
2023-11-27
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

This is a clinical trial, randomized, crossover, double-blind, and sham-controlled study. Participants will be randomly assigned to four groups: (1) Real peripheral electrical stimulation-PES (priming
(2) Sham PES (priming), followed by real tDCS-a
(3) Real cathodal tDCS (priming), followed by real tDCS-a
(4) Sham cathodal tDCS (priming), followed by real tDCS-a. The PES will be applied before tDCS, using a rectangular, bifasic, asymmetric current equipment (Neurodyn III Ibramed, Brazil) with two self-
E02.331.800

Sponsors

Universidade Federal do Delta do Parnaiba-UFDPar
Lead Sponsor
Universidade Federal do Delta do Parnaiba-UFDPar
Collaborator

Eligibility

Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Individuals of both sexes; aged 18 to 35 years; with no history of illnesses or previous surgeries and no complaints of pain (musculoskeletal or visceral)

Exclusion criteria

Exclusion criteria: Chronic pain; concomitant medication that may affect cognitive performance; pregnancy or possible history of pregnancy; drug or alcohol abuse or dependence; recent head injury (within the last 3 months); history of seizure or stroke; neurological; psychiatric diseases and rheumatologic

Design outcomes

Primary

MeasureTime frame
Activation of the pain inhibitory pathway, assessed by Conditioned Pain Modulation Test, during the first 30s.

Secondary

MeasureTime frame
Activation of the pain inhibitory pathway, assessed by Conditioned Pain Modulation Test, during the first 90s ;Activation of the pain inhibitory pathway, assessed by Conditioned Pain Modulation Test, post-60s

Countries

Brazil

Contacts

Public ContactRaquel Jacob

Universidade Federal do Delta do Parnaiba-UFDPar

raquelrocha@ufpi.edu.br+55 (86) 9 8108-6513

Outcome results

None listed

Source: REBEC (via WHO ICTRP)